Brazil to begin tracking numbers of HIV cases

December 27, 2012

(AP)—Brazilian health officials say doctors will be required to notify authorities of every HIV case in the nation.

Until now, doctors were only required to notify state and federal officials when patients developed AIDS.

Brazil's says Thursday the move is an effort to advance highly lauded efforts to combat AIDS.

All in Brazil can receive free drug treatment—a program that now reaches 223,000 people and costs the nation nearly $700 million a year.

have said they believe here are another 250,000 Brazilians infected with HIV, the virus that causes AIDS. But nobody knows for certain because up to now HIV cases haven't been tracked. Officials hope earlier treatment will prolong patients' lives.

Nearly 241,500 people died of AIDS in Brazil from 1980-2010.

Explore further: Mozambique launches Brazil-funded drugs plant to battle HIV

shares

Related Stories

Brazil expands its anti-AIDS program

August 29, 2012

(AP) —Brazil's anti-AIDS program will be expanded to include at least 35,000 more people, a Health Ministry official said Wednesday.

New UN AIDS deputy hails Brazil progress

December 22, 2012

The newly appointed deputy chief of the United Nations HIV-fighting program, Brazilian Luiz Loures, hailed his own country's achievements in the fight against the deadly global epidemic in an interview published Saturday.

Recommended for you

Targeting HIV in semen to shut down AIDS

August 18, 2015

There may be two new ways to fight AIDS—using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection, according ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.